61081-34-3 Usage
Description
1-[(methylsulfonyl)methyl]-4-nitrobenzene, commonly referred to as Dibenzosulfone, is a chemical compound characterized by the molecular formula C8H9NO4S. It manifests as a yellow crystalline solid and is recognized for its role in the synthesis of dyes, pigments, and pharmaceuticals. 1-[(methylsulfonyl)methyl]-4-nitrobenzene also serves as an intermediate in the production of various organic compounds, highlighting its versatility in chemical processes.
Uses
Used in Pharmaceutical Industry:
1-[(methylsulfonyl)methyl]-4-nitrobenzene is utilized as a key intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs and enhancing the efficacy of existing ones. Its chemical properties allow for the creation of diverse medicinal compounds, making it a valuable asset in the pharmaceutical sector.
Used in Dye and Pigment Industry:
In the dye and pigment industry, 1-[(methylsulfonyl)methyl]-4-nitrobenzene is employed as a precursor for the production of various dyes and pigments. Its chemical structure enables the creation of a wide range of colorants, which are essential for coloring textiles, plastics, and other materials.
Used in Organic Synthesis:
1-[(methylsulfonyl)methyl]-4-nitrobenzene is used as an intermediate in organic synthesis, facilitating the production of a variety of organic compounds. Its reactivity and functional groups make it a suitable candidate for use in the synthesis of complex organic molecules, broadening its applications in the chemical industry.
Safety Considerations:
Check Digit Verification of cas no
The CAS Registry Mumber 61081-34-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,0,8 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 61081-34:
(7*6)+(6*1)+(5*0)+(4*8)+(3*1)+(2*3)+(1*4)=93
93 % 10 = 3
So 61081-34-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H9NO4S/c1-14(12,13)6-7-2-4-8(5-3-7)9(10)11/h2-5H,6H2,1H3
61081-34-3Relevant articles and documents
NAMPT MODULATORS
-
Paragraph 0215, (2021/08/13)
Provided are compounds of Formula (II) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and p are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (II), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (II), or a pharmaceutically acceptable salt thereof.
Heterocyclic compound and preparation and application thereof
-
Paragraph 0110-0113, (2020/07/24)
The invention relates to bromodomain inhibitors, and provides a compound represented by a general formula I, a pharmaceutically acceptable salt, an enantiomer, a diastereoisomer, an atropisomer, a racemate, a polymorph, a solvate or an isotope-labeled compound (including deuterium substitution) thereof, a preparation method thereof, a pharmaceutical composition containing the same, and applicationthereof in pharmacy.
Bromine structural domain inhibitor compound and application thereof
-
Paragraph 0342-0345, (2019/08/02)
The invention relates to a bromine structural domain inhibitor and provides a compound shown in a general formula I, pharmaceutical salt, an enantiomer, a diastereoisomer, an atropisomer, racemate, apolymorphic substance and solvate of the compound or an isotope labelled compound (including a deuterium substituted compound), a preparation method of the compound, pharmaceutical composition containing the compound and an application of the above components in pharmaceuticals.
